Latest Casdin Capital, LLC Stock Portfolio
$1.35Billion
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Casdin Capital, LLC and it’s 13F Hedge Fund Stock Holdings
Casdin Capital, LLC is a hedge fund based in NEW YORK, NY. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $2.7 Billions. In it's latest 13F Holdings report, Casdin Capital, LLC reported an equity portfolio of $1.3 Billions as of 31 Mar, 2024.
The top stock holdings of Casdin Capital, LLC are RVMD, LAB, BLFS. The fund has invested 13.5% of it's portfolio in REVOLUTION MEDICINES INC and 12.5% of portfolio in STANDARD BIOTOOLS INC.
The fund managers got completely rid off SOMALOGIC INC (SLGC), FATE THERAPEUTICS INC (FATE) and LIANBIO (LIAN) stocks. They significantly reduced their stock positions in PLIANT THERAPEUTICS INC (PLRX), 4D MOLECULAR THERAPEUTICS IN (FDMT) and ILLUMINA INC (ILMN). Casdin Capital, LLC opened new stock positions in VERACYTE INC (VCYT), KYVERNA THERAPEUTICS INC and GINKGO BIOWORKS HOLDINGS INC (DNA). The fund showed a lot of confidence in some stocks as they added substantially to STANDARD BIOTOOLS INC (LAB), ALNYLAM PHARMACEUTICALS INC (ALNY) and AVIDITY BIOSCIENCES INC (RNA).
The top stock holdings of Casdin Capital, LLC are RVMD, LAB, BLFS. The fund has invested 13.5% of it's portfolio in REVOLUTION MEDICINES INC and 12.5% of portfolio in STANDARD BIOTOOLS INC.
The fund managers got completely rid off SOMALOGIC INC (SLGC), FATE THERAPEUTICS INC (FATE) and LIANBIO (LIAN) stocks. They significantly reduced their stock positions in PLIANT THERAPEUTICS INC (PLRX), 4D MOLECULAR THERAPEUTICS IN (FDMT) and ILLUMINA INC (ILMN). Casdin Capital, LLC opened new stock positions in VERACYTE INC (VCYT), KYVERNA THERAPEUTICS INC and GINKGO BIOWORKS HOLDINGS INC (DNA). The fund showed a lot of confidence in some stocks as they added substantially to STANDARD BIOTOOLS INC (LAB), ALNYLAM PHARMACEUTICALS INC (ALNY) and AVIDITY BIOSCIENCES INC (RNA).
New Buys
| Ticker | $ Bought |
|---|---|
| VERACYTE INC | 19,011,200 |
| KYVERNA THERAPEUTICS INC | 3,726,000 |
| GINKGO BIOWORKS HOLDINGS INC | 1,693,310 |
New stocks bought by Casdin Capital, LLC
Additions
| Ticker | % Inc. |
|---|---|
| STANDARD BIOTOOLS INC | 5,058 |
| ALNYLAM PHARMACEUTICALS INC | 83.59 |
| AVIDITY BIOSCIENCES INC | 77.32 |
| 2SEVENTY BIO INC | 69.12 |
| EXACT SCIENCES CORP | 54.76 |
| INTELLIA THERAPEUTICS INC | 29.31 |
| BEAM THERAPEUTICS INC | 27.84 |
| SAREPTA THERAPEUTICS INC | 6.21 |
Additions to existing portfolio by Casdin Capital, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| PLIANT THERAPEUTICS INC | -36.59 |
| 4D MOLECULAR THERAPEUTICS IN | -22.62 |
| ILLUMINA INC | -20.77 |
| REVOLUTION MEDICINES INC | -1.7 |
Casdin Capital, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| SOMALOGIC INC | -31,888,800 |
| FATE THERAPEUTICS INC | -7,667,000 |
| LIANBIO | -922,675 |
Casdin Capital, LLC got rid off the above stocks
Current Stock Holdings of Casdin Capital, LLC
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ABCL | ABCELLERA BIOLOGICS INC | 0.80 | 2,360,130 | 10,691,400 | UNCHANGED | 0.00 | |
| ABSI | ABSCI CORPORATION | 0.41 | 973,260 | 5,528,120 | UNCHANGED | 0.00 | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 3.98 | 358,000 | 53,503,100 | ADDED | 83.59 | |
| BEAM | BEAM THERAPEUTICS INC | 1.66 | 675,000 | 22,302,000 | ADDED | 27.84 | |
| BLFS | BIOLIFE SOLUTIONS INC | 12.01 | 8,707,160 | 161,518,000 | UNCHANGED | 0.00 | |
| BPMC | BLUEPRINT MEDICINES CORP | 2.30 | 326,378 | 30,960,200 | UNCHANGED | 0.00 | |
| CDXS | CODEXIS INC | 0.52 | 2,000,000 | 6,980,000 | UNCHANGED | 0.00 | |
| DNA | GINKGO BIOWORKS HOLDINGS INC | 0.13 | 1,459,750 | 1,693,310 | NEW | ||
| DNLI | DENALI THERAPEUTICS INC | 1.98 | 1,300,000 | 26,676,000 | UNCHANGED | 0.00 | |
| EXAI | EXSCIENTIA PLC | 0.09 | 213,900 | 1,223,510 | UNCHANGED | 0.00 | |
| EXAS | EXACT SCIENCES CORP | 3.34 | 650,000 | 44,889,000 | ADDED | 54.76 | |
| FATE | FATE THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 1.90 | 800,000 | 25,488,000 | REDUCED | -22.62 | |
| GLUE | MONTE ROSA THERAPEUTICS INC | 0.27 | 510,882 | 3,601,720 | UNCHANGED | 0.00 | |
| ILMN | ILLUMINA INC | 2.53 | 248,000 | 34,055,400 | REDUCED | -20.77 | |
| IPSC | CENTURY THERAPEUTICS INC | 1.00 | 3,206,380 | 13,402,700 | UNCHANGED | 0.00 | |
| KRON | KRONOS BIO INC | 0.01 | 123,839 | 160,991 | UNCHANGED | 0.00 | |
| LAB | STANDARD BIOTOOLS INC | 12.47 | 61,907,600 | 167,770,000 | ADDED | 5,058 | |
| LIAN | LIANBIO | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| NTLA | INTELLIA THERAPEUTICS INC | 3.83 | 1,875,000 | 51,581,200 | ADDED | 29.31 | |
| OMIC | SINGULAR GENOMICS SYSTEMS IN | 0.05 | 1,323,880 | 680,742 | UNCHANGED | 0.00 | |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 0.29 | 1,035,860 | 3,884,470 | UNCHANGED | 0.00 | |
| PLRX | PLIANT THERAPEUTICS INC | 1.11 | 1,000,000 | 14,900,000 | REDUCED | -36.59 | |
| RLAY | RELAY THERAPEUTICS INC | 4.58 | 7,423,570 | 61,615,700 | ADDED | 0.48 | |
| RNA | AVIDITY BIOSCIENCES INC | 3.96 | 2,084,840 | 53,205,100 | ADDED | 77.32 | |
| RVMD | REVOLUTION MEDICINES INC | 13.46 | 5,617,600 | 181,055,000 | REDUCED | -1.7 | |
| SLGC | SOMALOGIC INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| SMFR | GENEDX HOLDINGS CORP | 2.13 | 3,136,410 | 28,635,400 | ADDED | 1.32 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 0.26 | 150,000 | 3,570,000 | UNCHANGED | 0.00 | |
| SRPT | SAREPTA THERAPEUTICS INC | 10.29 | 1,069,000 | 138,393,000 | ADDED | 6.21 | |
| TNGX | TANGO THERAPEUTICS INC | 0.70 | 1,188,350 | 9,435,490 | UNCHANGED | 0.00 | |
| TNYA | TENAYA THERAPEUTICS INC | 2.62 | 6,732,970 | 35,213,400 | ADDED | 5.51 | |
| TSVT | 2SEVENTY BIO INC | 0.80 | 2,000,000 | 10,700,000 | ADDED | 69.12 | |
| VCYT | VERACYTE INC | 1.41 | 857,904 | 19,011,200 | NEW | ||
| VERV | VERVE THERAPEUTICS INC | 3.02 | 3,059,090 | 40,624,800 | ADDED | 1.66 | |
| STRUCTURE THERAPEUTICS INC | 3.56 | 1,116,870 | 47,868,900 | ADDED | 2.29 | ||
| NEUROGENE INC | 1.99 | 524,616 | 26,703,000 | UNCHANGED | 0.00 | ||
| KYVERNA THERAPEUTICS INC | 0.28 | 150,000 | 3,726,000 | NEW | |||
| PRIME MEDICINE INC | 0.19 | 367,175 | 2,570,220 | UNCHANGED | 0.00 |